Cargando…
Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?
Antipsychotics have been utilized as the standard treatment for schizophrenia regardless of illness phase where antipsychotic monotherapy (APM) is routinely recommended as the gold standard rather than antipsychotic polypharmacy (APP). However, approximately 20 to 40% of patients with schizophrenia...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Chonnam National University Medical School
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520369/ https://www.ncbi.nlm.nih.gov/pubmed/33014754 http://dx.doi.org/10.4068/cmj.2020.56.3.157 |